This company has been marked as potentially delisted and may not be actively trading. NASDAQ:VRAY ViewRay (VRAY) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About ViewRay Stock (NASDAQ:VRAY) 30 days 90 days 365 days Advanced Chart Get ViewRay alerts:Sign Up Key Stats Today's Range N/A50-Day Range$0.03▼$0.6552-Week Range N/AVolume108.50 million shsAverage Volume7.51 million shsMarket Capitalization$4.59 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado.Read More… Receive VRAY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ViewRay and its competitors with MarketBeat's FREE daily newsletter. Email Address VRAY Stock News HeadlinesViewRay Inc (VRAYQ) Earnings Dates & ReportsMay 27, 2024 | investing.comVRAY Jan 2025 2.000 callMarch 16, 2024 | finance.yahoo.com$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.April 27, 2025 | Stansberry Research (Ad)VRAY Jan 2025 0.500 putMarch 16, 2024 | finance.yahoo.comVRAY Jan 2025 0.500 callMarch 16, 2024 | finance.yahoo.comVRAY Jan 2025 3.000 putMarch 16, 2024 | finance.yahoo.comViewRay Inc VRAYQNovember 4, 2023 | morningstar.comNUBURU Appoints Brian Knaley as new CEONovember 1, 2023 | benzinga.comSee More Headlines VRAY Stock Analysis - Frequently Asked Questions How were ViewRay's earnings last quarter? ViewRay, Inc. (NASDAQ:VRAY) issued its quarterly earnings results on Monday, February, 27th. The company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.01. The company's revenue for the quarter was up 70.1% on a year-over-year basis. Does ViewRay have any subsidiaries? ViewRay subsidiaries include these companies: Vesuvius Acquisition Corp., ViewRay GmbH, and ViewRay Technologies Inc.. When did ViewRay IPO? ViewRay (VRAY) raised $52 million in an initial public offering (IPO) on the week of April 6th 2015. The company issued 4,000,000 shares at $12.00-$14.00 per share. Cowen and Company and Stifel served as the underwriters for the IPO and BTIG and Brean Capital were co-managers. What other stocks do shareholders of ViewRay own? Based on aggregate information from My MarketBeat watchlists, some other companies that ViewRay investors own include Alibaba Group (BABA), Meta Platforms (META), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), NVIDIA (NVDA), Bristol-Myers Squibb (BMY) and Amarin (AMRN). Company Calendar Last Earnings2/27/2023Today4/26/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:VRAY CIK1597313 Webwww.viewray.com Phone(440) 703-3210Fax800-417-3459Employees295Year Founded2004Profitability EPS (Most Recent Fiscal Year)($0.60) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-107,330,000.00 Net Margins-104.30% Pretax Margin-104.30% Return on Equity-120.48% Return on Assets-42.39% Debt Debt-to-Equity RatioN/A Current Ratio1.16 Quick Ratio0.91 Sales & Book Value Annual Sales$105.86 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.45 per share Price / BookN/AMiscellaneous Outstanding Shares183,402,000Free Float178,817,000Market Cap$4.59 million OptionableOptionable Beta0.81 Social Links 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:VRAY) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViewRay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.